This guide outlines key cosmetic ingredient compliance steps for US, Canada, EU, and UK markets, covering ingredient checks, banned substances, INCI labeling, regulations (EU, UK, US), GMP, claims substantiation, and…
FDA and Health Canada updates tighten timelines, increase evidence demands, and require eCTD v4.0 submissions. Leverage accelerated pathways (PDUFA, NOC/c) and ICH Q12 for post-approval management.
This guide outlines strategies for managing multi-jurisdictional healthcare regulations by understanding key rules, coordinating compliance, leveraging regulatory tools, and maintaining robust quality management systems for successful market entry.
Implement a proactive regulatory intelligence program with dedicated teams, data analytics, and clear communication to align with FDA and Health Canada rules, anticipate changes, reduce risks, and accelerate product lifecycle…
Expanding natural health products in the US and Canada requires navigating distinct FDA and Health Canada regulations, ensuring bilingual labeling, GMP compliance, accurate claims, and thorough market entry documentation.
Effective post-approval regulatory support ensures sustained compliance, safety, and market advantage through monitoring, change control, labeling updates, vigilance, complaint handling, license management, PSURs, recall readiness, and GMP audits.
A winning North American medical device submission strategy requires mastering FDA 510(k), PMA, and Health Canada processes, implementing ISO 13485 risk management, human factors engineering, cybersecurity, and leveraging FDA eSTAR…
To enter the North American cosmetic market, comply with US MoCRA by registering products, ensuring safety, and following GMPs; meet Canadian bilingual labeling and Hotlist rules; and navigate state chemical…
Call Now Button